Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

Imlifidase as novel treatment strategy in anti-neutrophil cytoplasmic antibody–induced pulmonary-renal syndrome

Item Type:Letter
Title:Imlifidase as novel treatment strategy in anti-neutrophil cytoplasmic antibody–induced pulmonary-renal syndrome
Creators Name:Enghard, P., Zickler, D., Sonnemann, J., Schneider, W., Lurje, G., Elezkurtaj, S., Eckardt, K.U. and Schreiber, A.
Keywords:Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Antineutrophil Cytoplasmic Antibodies, Glomerulonephritis, Hemorrhage, Lung Diseases
Source:Kidney International
ISSN:0085-2538
Publisher:Elsevier
Volume:100
Number:6
Page Range:1344-1345
Date:December 2021
Official Publication:https://doi.org/10.1016/j.kint.2021.09.020
PubMed:View item in PubMed

Repository Staff Only: item control page

Open Access
MDC Library